Product NDC: | 65483-895 |
Proprietary Name: | LOTRONEX |
Non Proprietary Name: | alosetron hydrochloride |
Active Ingredient(s): | 1 mg/1 & nbsp; alosetron hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65483-895 |
Labeler Name: | Prometheus Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021107 |
Marketing Category: | NDA |
Start Marketing Date: | 20090209 |
Package NDC: | 65483-895-03 |
Package Description: | 30 TABLET in 1 BOTTLE (65483-895-03) |
NDC Code | 65483-895-03 |
Proprietary Name | LOTRONEX |
Package Description | 30 TABLET in 1 BOTTLE (65483-895-03) |
Product NDC | 65483-895 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | alosetron hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090209 |
Marketing Category Name | NDA |
Labeler Name | Prometheus Laboratories Inc. |
Substance Name | ALOSETRON HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |